Fairmount Funds Management »

Protagonist Therapeutics shares owned by Fairmount Funds Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Fairmount Funds Management from 13F filings

Historical chart of Fairmount Funds Management investment in Protagonist Therapeutics

Jul 2022Jan 2023Jul 2023Jan 2024Jul 202415M20M25M30M600k700k800k900k
Value ($)Share countHistorical PTGX position of Fairmount Funds Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Fairmount Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Fairmount Funds Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $32M 932k 34.65
2024-03-31 $27M 932k 28.93
2022-03-31 $13M 550k 23.68